Topic Paragraphs
Recalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
Jul 15
Krasniy Oktyabr Inc. USA Issues Alert on Eviscerate Dry Salted Vobla “Aral Silver”
Food & Beverages
Jul 15
Update – Sandoz Inc. Issues Voluntary Nationwide Recall Expansion of One Additional Lot of Cefazolin for Injection Due to Vials Being Potentially Mislabeled as Penicillin G Potassium for Injection
Jul 14
World Market Recalls Emek Spread Pistachio Cacao Cream with Kadayif Due to Salmonella Contamination
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024
The 2024 New Drug Therapy Approvals report features drug approvals that CDER considers likely to have a significant impact on public health.
Youth Tobacco Product Use Continues to Decline as FDA Actions Build Momentum
FDA’s ongoing efforts serve to make tobacco-related disease and death part of our nation’s past, ensuring a healthier future for our youth.
Upholding Public Trust: FDA Office of Criminal Investigations’ Crucial Role in Bringing Drug Criminals to Justice
OCI investigators have been conducting and coordinating criminal investigations of suspected illegal activities involving FDA-regulated products.
Recently Published Guidances
Jul 15
Recommendations for Testing Blood Donations for Hepatitis B Surface Antigen
Biologics
Jul 03
Small Volume Parenteral Drug Products and Pharmacy Bulk Packages for Parenteral Nutrition: Aluminum Content and Labeling Recommendations
Drugs
Jul 02
Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment
Biologics, Drugs